Hims & Hers Health (HIMS) FCF Margin (2020 - 2026)
Hims & Hers Health (HIMS) posted FCF Margin of 9.79% for Q1 2026, down 17.07% sequentially from 11.8% in Q4 2025, and up 61.0% YoY from 6.08% in Q1 2025.
Hims & Hers Health (HIMS) FCF Margin (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported FCF Margin for 7 years, with the latest figure at 9.79% in Q1 2026.
- Quarterly FCF Margin rose 61.0% year-over-year to 9.79% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.84% (down 380.0% YoY) and the FY2025 annual result came in at 11.7%, down 530.0% from the prior year.
- FCF Margin slipped to 9.79% in Q1 2026 per HIMS's latest filing, from 11.8% in the prior quarter.
- Over five years, FCF Margin peaked at 21.5% in Q4 2024 and troughed at 19.15% in Q1 2022.
- A 5-year average of 7.15% and a median of 9.17% in 2025 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2025: FCF Margin jumped 2597 bps in 2022, then sank 1179 bps in 2025.
- Over 5 years, FCF Margin stood at 4.01% in 2022, then surged by 216 bps to 4.65% in 2023, then jumped by 362 bps to 21.5% in 2024, then tumbled by 45 bps to 11.8% in 2025, then fell by 17 bps to 9.79% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 9.79%, 11.8%, and 20.01% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | -8.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.21% |
| Mar 31, 2026 | 9.79% |
| Dec 31, 2025 | 11.80% |
| Sep 30, 2025 | 20.01% |
| Jun 30, 2025 | 5.18% |
| Mar 31, 2025 | 9.17% |
| Dec 31, 2024 | 21.50% |
| Sep 30, 2024 | 16.98% |
| Jun 30, 2024 | 16.98% |
| Mar 31, 2024 | 9.27% |
| Dec 31, 2023 | 4.65% |
| Sep 30, 2023 | 10.50% |
| Jun 30, 2023 | 6.16% |
| Mar 31, 2023 | 4.29% |
| Dec 31, 2022 | -4.01% |
| Sep 30, 2022 | 4.15% |
| Jun 30, 2022 | -5.65% |
| Mar 31, 2022 | -19.15% |
| Dec 31, 2021 | -3.34% |
| Sep 30, 2021 | -21.82% |